HOME >> BIOLOGY >> NEWS
Jefferson scientists find gene expression pattern may predict behavior of leukemia

involves changes in miRNA, and that you can predict the behavior of CLL depending on the miRNA genetic signature," says Dr. Croce. "We think we might be able to predict CLL behavior based on the miR-16 signature because that is the only common denominator between the two signatures with good prognosis." But before using miRNA expression as any kind of clinical biomarker, says Dr. Croce, the results need to be verified in a clinical trial screening thousands of patients.

Dr. Croce and his colleagues had previously shown that deletions in miRNA genes were involved in B-cell CLL. They also had reported that human miRNA genes are frequently located at sites of the genome that are altered in human cancers.

The work might enable scientists to gain a better understanding of the roles of miRNAs in cancer and provide targets for future drug development.


'"/>


10-Aug-2004


Page: 1 2

Related biology news :

1. Jefferson Lab detector technology aids development of cystic fibrosis therapy
2. Jefferson researchers develop microchip to track genetic signature of cancer and normal tissue
3. Jefferson scientists use gene therapy to restore function of damaged heart cells in lab
4. Jefferson researchers uncover biochemical clues to how cells migrate in embryos
5. Jefferson and Brigham and Womens researchers find blue light important for setting biological clock
6. Jefferson Lab experiment generates THz radiation 20,000 times brighter than anyone else
7. Jefferson scientists show neural stem cells can become dopamine-making brain cells in laboratory
8. Jefferson scientists show how collagen gene mutation leads to osteoarthritis
9. Jefferson scientists use gene repair technique to change albino mice hairs to black
10. Jefferson scientists show drug is effective against a Hepatitis C Virus model in the laboratory
11. Jefferson scientists propose mechanism to control the bodys red blood cell and platelet production

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/11/2020)... ... February 11, 2020 , ... The ... medical device accelerator in Port Covington, Baltimore. The newly formed company is developing ... addressed to manage increased demand for home dialysis treatments. The start-up company will ...
(Date:2/5/2020)... (PRWEB) , ... February 04, 2020 , ... ... Trademark Office (USPTO) issued the company a second patent related to proprietary liquid ... of Allowance compliments another patent from the USPTO issued on December 3, 2019. ...
(Date:1/29/2020)... (PRWEB) , ... January 29, 2020 , ... ... receptor and in vitro toxicology testing solutions, has announced a record earnings year ... upcoming weeks, INDIGO showed more than a twenty percent increase in revenue and ...
Breaking Biology News(10 mins):
(Date:1/27/2020)... ... January 27, 2020 , ... Cerebyte, ... cloud and mobile computing, today announced the availability of neuroscience of transformational leadership ... use the latest neuroscience of leadership and change research to become great transformational ...
(Date:1/24/2020)... ... 24, 2020 , ... The impact of new medicines, procedures, ... and clinical services during the first two decades of the 21st century have ... Slone Partners celebrates its 20th anniversary this year, its evolution as a ...
(Date:1/22/2020)... ... January 20, 2020 , ... ... with WAVE Electronics, the largest independent electronics distributor in the US, to make ... Smart Home Systems with leading smart home products from a single fulfillment partner. ...
(Date:1/22/2020)... Conn. (PRWEB) , ... January 21, 2020 , ... ... (CTC) liquid biopsy from a simple blood draw, today announced the sale of the ... Health. The Rare Scope will be used in clinical cancer research. , “The RareScope ...
Breaking Biology Technology:
Cached News: